U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06917469) titled 'Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO' on April 01.
Brief Summary: Ovarian cancer (OC) is the leading cause of death from gynecologic cancer. It is estimated that 22,440 new cases of EOC will be diagnosed in 2017 with an estimated 14,080 EOC deaths. Several different histological subtypes of OC can be identified.
Over 90% of malignant ovarian tumors are epithelial cancers (EOC), which are then classified into 5 broad histological subtypes: serous, endometrioid, mucinous, clear cell and mixed or carcinosarcomatous mullerian tumors. Almost 10 years ago, a new classification was proposed tha...